Tirzepatide Trial Shows Promising Results for New Type 2 Diabetes Drug - GoodRx

Content
    Tirzepatide, a new drug from Eli Lilly, has shown promising results in clinical trials, including lower A1C levels and weight loss in trial participants.
    https://ift.tt/3dfKADzRead More

    FULL ARTICLE
    READ MORE